To the Editor: It has been claimed that melatonin has many actions,mostly on the basis of uncontrolled studies of widely varyingoral doses. It is commonly assumed that the administered dosageof melatonin bears a direct relation to its circulating concentration.
We estimated the bioavailability of oral melatonin by determiningthe pharmacokinetics of intravenous bolus and oral doses ofmelatonin (Sigma Chemical, St. Louis) in four normal men (21to 32 years old), who were given 20 µg intravenously onone occasion and 500 µg orally on a second occasion, withan interval of at least one month between . . . [Full Text of this Article]
References
This article has been cited by other articles:
Shamseer, L., Vohra, S.
(2009). Complementary, Holistic, and Integrative Medicine: Melatonin. Pediatr. Rev.
30: 223-228
[Full Text]
Naguib, M., Goldstein, P. A.
(2009). All Results Count. Anesth. Analg.
108: 1058-1061
[Full Text]
Markantonis, S. L., Tsakalozou, E., Paraskeva, A., Staikou, C., Fassoulaki, A.
(2008). Melatonin Pharmacokinetics in Premenopausal and Postmenopausal Healthy Female Volunteers. J Clin Pharmacol
48: 240-245
[Full Text]
Blask, D. E., Dauchy, R. T., Sauer, L. A., Krause, J. A.
(2004). Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. Carcinogenesis
25: 951-960
[Abstract][Full Text]
Kovács, J., Brodner, W., Kirchlechner, V., Arif, T., Waldhauser, F.
(2000). Measurement of Urinary Melatonin: A Useful Tool for Monitoring Serum Melatonin after Its Oral Administration. J. Clin. Endocrinol. Metab.
85: 666-670
[Abstract][Full Text]